Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117757493 | 11775749 | 3 | F | 201208 | 20160701 | 20151125 | 20160830 | PER | US-JNJFOC-20151103437 | JANSSEN | 17.79 | YR | T | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117757493 | 11775749 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 9 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 10 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | 1 | MG | TABLETS | ||||||
117757493 | 11775749 | 11 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117757493 | 11775749 | 1 | Drug therapy |
117757493 | 11775749 | 2 | Drug therapy |
117757493 | 11775749 | 3 | Impulsive behaviour |
117757493 | 11775749 | 4 | Impulsive behaviour |
117757493 | 11775749 | 5 | Irritability |
117757493 | 11775749 | 6 | Irritability |
117757493 | 11775749 | 7 | Agitation |
117757493 | 11775749 | 8 | Agitation |
117757493 | 11775749 | 9 | Attention deficit/hyperactivity disorder |
117757493 | 11775749 | 10 | Attention deficit/hyperactivity disorder |
117757493 | 11775749 | 11 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117757493 | 11775749 | Gynaecomastia | |
117757493 | 11775749 | Off label use | |
117757493 | 11775749 | Product use issue | |
117757493 | 11775749 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117757493 | 11775749 | 1 | 201209 | 201211 | 0 | |
117757493 | 11775749 | 2 | 201208 | 201209 | 0 | |
117757493 | 11775749 | 3 | 201209 | 201211 | 0 | |
117757493 | 11775749 | 4 | 201208 | 201209 | 0 | |
117757493 | 11775749 | 5 | 201208 | 201209 | 0 | |
117757493 | 11775749 | 6 | 201209 | 201211 | 0 | |
117757493 | 11775749 | 7 | 201209 | 201211 | 0 | |
117757493 | 11775749 | 8 | 201208 | 201209 | 0 | |
117757493 | 11775749 | 9 | 201209 | 201211 | 0 | |
117757493 | 11775749 | 10 | 201208 | 201209 | 0 |